Related references
Note: Only part of the references are listed.Syndecan-1 in Breast Cancer Stroma Fibroblasts Regulates Extracellular Matrix Fiber Organization and Carcinoma Cell Motility
Ning Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10
Lihua Sun et al.
BRAIN RESEARCH (2011)
Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b
Xiaokun Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
Caroline Rousseau et al.
EJNMMI RESEARCH (2011)
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer
Bethany N. Hannafon et al.
BREAST CANCER RESEARCH (2011)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness
M. Goette et al.
ONCOGENE (2010)
Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites
Doron Betel et al.
GENOME BIOLOGY (2010)
Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion
Shuh Narumiya et al.
CANCER AND METASTASIS REVIEWS (2009)
Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
Emilie Bousquet et al.
CANCER RESEARCH (2009)
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Viktoriya Nikolova et al.
CARCINOGENESIS (2009)
Stromal Matrix Protein Expression Following Preoperative Systemic Therapy in Breast Cancer
Anna-Maria Tokes et al.
CLINICAL CANCER RESEARCH (2009)
Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
DeannaLee M. Beauvais et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
Behzad Kharabi Masouleh et al.
JOURNAL OF IMMUNOLOGY (2009)
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
Raffaele Baffa et al.
JOURNAL OF PATHOLOGY (2009)
Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Yu-Wen E. Chang et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2009)
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
D. Loussouarn et al.
BRITISH JOURNAL OF CANCER (2008)
Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization
Daniel P. Fitzgerald et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Role of Rho GTPases in breast cancer
Yong Tang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO
Tobias Berg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (β4GalT-7) deficient form of Ehlers-Danlos syndrome
Martin Goette et al.
HUMAN MOLECULAR GENETICS (2008)
The microRNA.org resource: targets and expression
Doron Betel et al.
NUCLEIC ACIDS RESEARCH (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPα interaction
T. Fujimoto et al.
EMBO JOURNAL (2007)
Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development
S. P. McDermott et al.
ONCOGENE (2007)
Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling
L. Sun et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
miRGen: a database for the study of animal microRNA genomic organization and function
Molly Megraw et al.
NUCLEIC ACIDS RESEARCH (2007)
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
Martin Goette et al.
BREAST CANCER RESEARCH (2007)
Heparanase, hyaluronan, and CD44 in cancers:: A breast carcinoma perspective
Martin Gotte et al.
CANCER RESEARCH (2006)
MicroRNAs and the hallmarks of cancer
T. Dalmay et al.
ONCOGENE (2006)
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype
Fusun Baba et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells
Alexander Koenig et al.
CANCER RESEARCH (2006)
Syndecan-1 expression by stromal. broblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis
T Maeda et al.
ONCOGENE (2006)
Therapeutic value of glycosaminoglycans in cancer
George W. Yip et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Regulatory mechanisms controlling human E-cadherin gene expression
YN Liu et al.
ONCOGENE (2005)
A RUNX/AML-binding motif residing in a novel 13-bp DNA palindrome may determine the expression of the proximal promoter of the human uPA gene
E Kopf et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo
JY Pillé et al.
MOLECULAR THERAPY (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Syndecan-4 regulates ATF-2 transcriptional activity in a Rac1-dependent manner
S Saoncella et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours
D Mennerich et al.
EUROPEAN JOURNAL OF CANCER (2004)
Prognostic value of syndecan-1 expression in breast cancer
M Leivonen et al.
ONCOLOGY (2004)
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi et al.
CANCER (2003)
Rho regulates p21CIP1 cyclin D1, and checkpoint control in mammary epithelial cells
M Liberto et al.
ONCOGENE (2002)
Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments
P Zimmermann et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Share Paper
